Form 4 for AURA Aura Biosciences, Inc.
Accepted 2022-12-15 00:00:00 ET · period of report 2022-12-01 · accession 0000899243-22-038695 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-12-15 | 2022-12-01 | AURA | Johnson David Michael | Dir | P - Purchase | $12.37 | +10.0K | 15.0K | +200% | +$123.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-01 | P | A | 5,000 | $12.37 | 15,000 | I By NEJ09 IRREVOCABLE TRUST | — | — | (F1) The shares are held by the NEJ09 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee. |
| 2 | Common | Common Stock | 2022-12-01 | P | A | 5,000 | $12.37 | 15,000 | I By NEJ12 IRREVOCABLE TRUST | — | — | (F2) The shares are held by the NEJ12 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee. |